Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • Life
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner

COVID-19 roundup: Arthritis drugs, blood clots, mu's resistance

by Reuters

Sep 12, 2021 - 11:25 am GMT+3
A person wears multiple face coverings during the pandemic-delayed State of Maine Bicentennial Parade, in Lewiston, Maine, U.S., Aug. 21, 2021. (AP Photo)
A person wears multiple face coverings during the pandemic-delayed State of Maine Bicentennial Parade, in Lewiston, Maine, U.S., Aug. 21, 2021. (AP Photo)
by Reuters Sep 12, 2021 11:25 am
RECOMMENDED
International scientists have voted for new metric prefixes to express the world's largest and smallest measurements. (Shutterstock Photo)

Say hello to quettameters: Scientists decide on new metric prefixes

science

In this week's roundup, the latest scientific research on the coronavirus and efforts to find treatments and vaccines suggest that an arthritis drug may reduce risk of death in high-risk COVID-19 patients, mu variant's resistance to antibodies may provide insight into the virus when developing vaccines and loss of smell may be followed by smell distortions.

Arthritis drug in high-risk patients

Hospitalized COVID-19 patients at high risk for becoming critically ill and dying had significantly better outcomes if they received the anti-inflammatory drug anakinra, researchers have found.

In order to test the drug, sold as Kineret by Sweden's Sobi Inc., the researchers looked for patients with high blood levels of a protein called suPAR, which is linked to higher odds of needing mechanical breathing assistance and death from COVID-19.

The 594-patient trial tested anakinra, which blocks the effects of inflammatory proteins IL-1-alpha and IL-1-beta, against a placebo. The risk of death was 55% lower in patients who received anakinra, and 80% lower for the sickest patients in the trial, the researchers reported in Nature Medicine.

"The clinical benefit with anakinra treatment was already apparent from Day 14, and this is of clinical importance because the first 14 days is the period during which a patient is expected to worsen. Anakinra benefit was maintained until Day 28," they said.

They note that measuring suPAR allows for a more personalized treatment approach, but its use to guide COVID-19 treatment could be problematic because the tests are not available in every hospital.

Heart drugs and blood clots

Drugs that prevent blood clots after procedures to unclog heart arteries might also be useful for clot prevention in patients with COVID-19, new data suggests.

The coronavirus is known to affect genes that control platelets, fragments in the blood that form clots. The inflammatory proteins generated by the virus cause platelets to become "hyperreactive" and form clots more easily and more often.

In test tube experiments described Wednesday in Science Advances, researchers found that anticoagulants used after coronary stenting – clopidogrel, sold as Plavix by Bristol Myers Squibb and Sanofi, and ticagrelor, sold as Brilinta by AstraZeneca – keep COVID-19 patients' platelets from becoming over-activated by blocking the P2Y12 protein on their surface.

If additional studies confirm their findings, these P2Y12 inhibitors "may represent a particularly attractive therapy" for reducing the risk of inflammation-related blood clots in COVID-19, the authors say.

Mu variant's escape from antibodies

The ability of the Mu variant of the coronavirus to escape from antibodies and vaccines can aid in preparations against other emerging variants, Japanese researchers say.

The variant has driven outbreaks in Colombia and is now classified as a "variant of interest" by the World Health Organization (WHO), although it appears unlikely to overtake the far more prevalent delta variant.

In test tube experiments, researchers found that Mu is "highly resistant" to antibodies in blood samples from COVID-19 survivors and from people who got the mRNA vaccine from Pfizer and BioNTech.

In fact, the spike used by the virus to break into cells was more resistant to neutralization than all other currently recognized variants of interest and variants of concern, the researchers reported Tuesday on bioRxiv ahead of peer review.

Dr. Eric Topol of the Scripps Clinic in La Jolla, California, who was not involved in the research, noted in a tweet Wednesday that delta's high infectiousness surpasses Mu's ability to escape from antibodies.

Nevertheless, study co-author Kei Sato of the University of Tokyo said understanding how variations in spike proteins affect the potency of neutralization antibodies is important for developing new vaccines and predicting breakthrough infections.

Loss of smell, other smell distortions

Many people who lose their sense of smell due to COVID-19 eventually regain it, but some survivors later report smell distortions and unexplained smells, a new study found.

Researchers analyzed survey responses from 1,468 individuals who had been diagnosed with COVID-19 between April and September 2020 and had suffered a loss of smell and taste at the start of their illness.

Early on, about 10% also reported smell distortions, or parosmia, and unexplained smells, known as phantosmia.

At an average of six to seven months after becoming ill and first reporting loss of smell, roughly 60% of women and 48% of men had regained less than 80% of their pre-illness smell ability, and rates of smell distortions and imaginary smells had increased, the researchers reported on medRxiv ahead of peer review.

Roughly 47% reported parosmia, saying, for example, "some things now smell like chemicals." About 25% reported phantosmia. "Sometimes I can smell burning but no one else around me can," one respondent reported.

Persistent smell problems were seen more often in survivors with more symptoms overall, "suggesting it may be a key marker of long COVID-19," the authors said.

RECOMMENDED
International scientists have voted for new metric prefixes to express the world's largest and smallest measurements. (Shutterstock Photo)

Say hello to quettameters: Scientists decide on new metric prefixes

science
  • shortlink copied
  • Last Update: Sep 13, 2021 11:33 am
    RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    covid-19 roundup covid-19 pandemic arthritis hospitalization mu variant covid-19 variants covid-19 vaccines
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    A U.S. Air Force airman marshals an F-16 Fighting Falcon aircraft assigned to the 480th Fighter Squadron, at the 86th Air Base near Fetesti, Romania, Feb. 17, 2022. (Reuters Photo)

    Türkiye warns of 'price' if US fails to deliver long-sought fighter jets

    F-16-FIGHTER-JETS
    Tourists visit the courtyard of the Süleymaniye Mosque on a sunny day in Istanbul, Türkiye, January 2023. (EPA Photo)

    Türkiye raises bets as foreign arrivals near record, tourism revenues boom

    tourism-in-Türkiye

    Türkiye inks $200M deal with S.Korean firm for parts of MBT Altay

    altay-tank

    Hungary slams Sweden's 'stupidity' on NATO row with Türkiye

    türkiye-hungary-relations
    No Image
    Up and away: Chile's Cumbres Balloon Festival 2022
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021